Edurne García Vidal
Edurne García Vidal obtained a degree in Biochemistry from the Autonomous University of Barcelona (UAB) in 2013. She continued her studies at the University of Barcelona (UB), where she completed an MSc in Genetics and Genomics in 2014, developing her post-graduate project at the Centre for Genomic Regulation (CRG) in Barcelona and undertaking her practical sessions in the clinical laboratory of the Dr. Josep Trueta University Hospital (Girona). In 2015 she worked at the ISOPlexis Germplasm Bank in Portugal and commenced doctoral studies at IrsiCaixa in 2016.
A protein synthesis routes.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.
Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.